re: cce
You only have to look at the chart to realise that the impact of FDA approval and other positive news has not been factoired into the price
"We continue to believe that CCE will provide an attractive speculative investment however the stock will be exposed to any delays the company experiences in generating sales revenues from both its CellSpray and ReCell products." Hell - I wonder what these fellows say about biotechs that have not developed their products to tangible sales
CCE Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
